+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance, Vol 256. Progress in Brain Research

  • ID: 5018899
  • Book
  • October 2020
  • Region: Global
  • 358 Pages
  • Elsevier Science and Technology
1 of 2

Progress in Brain Research series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

  • Covers all key aspects of current research on 5-HT interaction with other neurotransmitters
  • Provides extensively referenced chapters, thus giving readers a comprehensive list of resources on topics covered
  • Includes comprehensive and in-depth background information written in a clear form that is accessible to both specialists and non-specialists
Note: Product cover images may vary from those shown
2 of 2
Part 1: Serotonin in the CNS 1. The multiple facets of serotonergic modulation on brain functions Giuseppe Di Giovanni 2. Anatomical and neurochemical organization of the serotonergic system in the mammalian brain Harry Steinbusch 3. 5-HT2A/2C Receptors in the Brain Cristiano Bombardi

Part 2: Serotonin-dopamine interactions 4. Electrophysiological and neurochemical bases for an interaction of serotonin on central dopaminergic neurons Giuseppe Di Giovanni 5. The complex nature of serotonin-dopamine neurons interaction in primate model of Parkinson's disease Véronique Sgambato 6. The status of serotonergic system in presymptomatic and symptomatic stages of Huntington disease and corresponding animal models Anthony Hannan 7. Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias Manolo Carta 8. The serotonergic agent L-DOPA in the treatment of Parkinson's disease Marios Politis

Part 3: Serotonin-Glutamate interaction 9. Cortical influences of serotonin on pyramidal cells Gerard Joseph Marek 10. The interaction of serotonin with noradrenergic, dopaminergic, cholinergic, and opioid systems in Alzheimer's disease Goran Simic 11. Serotonergic controls upon the glutamatergic neurons of the subthalamic nucleus Luisa Ugedo
Note: Product cover images may vary from those shown
3 of 2